Management tracks: Canbridge, Averum, WindMIL
Cancer and rare disease company Canbridge Pharmaceuticals Inc. (Beijing, China) hired Glenn Hassan as CFO and CBO and Gerald Cox as chief development strategist and interim CMO. Hassan, who was director, cross border healthcare investment banking at China Renaissance Capital, succeeds CBO and SVP of Corporate Strategy and Development Paul Wagner, who is now CEO of ForteBio Inc. (Menlo Park, Calif.). Cox founded Gerald Cox Rare Care Consulting and served as CMO at Editas Medicine Inc. (NASDAQ:EDIT). He succeeds CMO May Orfali, who left for personal reasons.
Adverum Biotechnologies Inc. (NASDAQ:ADVM) hired Thomas Leung as CFO. He succeeds Leone Patterson, who was promoted to president and CEO of the gene therapy company in October. Leung was VP, business operations at women’s health genetic testing company Counsyl Inc., which was acquired by molecular diagnostics company Myriad Genetics Inc. (NASDAQ:MYGN) last year...